Category: Business/Financial News
Waltham nerve testing equipment manufacturer looks to boost sales with restructuring as it says goodbye to former vice president of diagnostic device sales Monty Hukill.
NeuroMetrix is reshuffling the deck in an effort to recover from the $3.7 million it spent to settle a federal kickbacks beef and its dismal results for fiscal 2008.
The Waltham-based nerve testing equipment maker is restructuring its U.S. sales operation into three divisions and saying goodbye to former VP of diagnostics device sales Monty Hukill.
Billerica mass spectrometry equipment maker opens facility to showcase its new maXis device.
Bruker Daltonics opened a demonstration facility for its new, ultra-high resolution time-of-flight maXis mass spectrometer.
The Billerica mass spectrometry equipment maker also said it installed the devices, which it says bridge the gap between ultra-high mass resolution and fast UHPLC separations, in several research labs in the U.S. including the Vanderbilt University School of Medicine and the University of Illinois at Urbana.
Bruker Daltonics is a division of Bruker Corp., a Billerica-based scientific instruments manufacturer.
Contract manufacturer adds another 1,500-square-foot clean room to its Rhode Island HQ.
Ximedica added another 1,500-square-foot clean room to its headquarters in Providence, the medtechinsider website reported.
The contract manufacturer now offers a pair of Class 7 clean rooms, a white assembly space and additional manufacturing space at its 80,000-square-foot home base.
After a round of layoffs last year and a manufacturing move to China, Covidien closes its Watertown, N.Y., plant, leaving nearly 250 out of work.
Covidien has been clearing the deck in an effort to weather the economic tsunami that's battered manufacturers particularly hard, according to news reports.
The Mansfield-based medical devices, imaging solutions, pharmaceutical products and medical supplies maker cut 40 full-time positions last January at its Watertown, N.Y., plant and moved production of four of the facility's product lines to Shanghai.
Inventors Christopher and Sonia Hillios are developing the Confidisc to help diabetics and others get over their fear of injections.
A Southampton couple is developing a simple medical device with a lofty aim: easing injection anxiety for diabetics and other patients.
Christopher and Sonia Hillios are awaiting patent approval for their Confidisc concept, an injection aid for syringes and injection pens, Mass High Tech reported.
Confidisc, a 1.25-in. diameter, polymer-based disk, is designed to reduces injection anxiety and pain perception, according to its creators.
And although it's projected to cost only about a dollar, its potential market includes about 20 million diabetics in the United States alone.
The Advanced Medical Technology Assn. formulates guidelines for direct-to-consumer marketing of medical devices, asking members to carefully police their ad campaigns.
Looking to head consumer advocates, regulators and members of Congress off at the pass, the Advanced Medical Technology Association came up with a set of guidelines for medical device makers' direct-to-consumer marketing campaigns.
The issue has attracted the attention of consumer advocates after high-profile marketing campaigns by Johnson & Johnson and Biomet featuring Duke University basketball coach Mike Krzyzewski and former Olympic gymnast Mary Lou Retton.
The biotech industry is one of the sole bright spots in the Federal Reserve Bank’s “beige book” report on New England’s economy.
The New England economy is still in a tailspin, according to the Federal Reserve Bank’s “beige book” report, with the exception of the region’s biotech industry.
Most manufacturers reported year-over-year revenue declines, according to the report, and almost all said they expect first-quarter sales to come in below last year’s levels.
But biopharmaceutical sales are still on the upswing, growing at a double-digit clip, and manufacturers of innovative products (like medical devices) reported that exports are holding their own compared with last year.
And although about half of the company’s surveyed by the Fed reported laying off workers or cutting back hours, the biotech sector is on track for employment growth.